• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型脊髓性肌萎缩症婴儿的呼吸肌功能

Respiratory muscle function in infants with spinal muscular atrophy type I.

作者信息

Finkel Richard S, Weiner Daniel J, Mayer Oscar H, McDonough Joseph M, Panitch Howard B

机构信息

Divisions of Neurology, Nemours Children's Hospital, Orlando, Florida.

出版信息

Pediatr Pulmonol. 2014 Dec;49(12):1234-42. doi: 10.1002/ppul.22997. Epub 2014 Apr 29.

DOI:10.1002/ppul.22997
PMID:24777943
Abstract

OBJECTIVE

To determine the feasibility and safety of respiratory muscle function testing in weak infants with a progressive neuromuscular disorder.

RATIONALE

Respiratory insufficiency is the major cause of morbidity and mortality in infants with spinal muscular atrophy type I (SMA-I).

HYPOTHESIS

Tests of respiratory muscle strength, endurance, and breathing patterns can be performed safely in SMA-I infants. Useful data can be collected which parallels the clinical course of pulmonary function in SMA-I.

STUDY DESIGN AND SUBJECT SELECTION

An exploratory study of respiratory muscle function testing and breathing patterns in seven infants with SMA-I seen in our neuromuscular clinic. Measurements were made at initial study visit and, where possible, longitudinally over time.

METHODOLOGY

We measured maximal inspiratory (MIP) and transdiaphragmatic pressures, mean transdiaphragmatic pressure, airway occlusion pressure at 100 msec of inspiration, inspiratory and total respiratory cycle time, and aspects of relative thoracoabdominal motion using respiratory inductive plethysmography (RIP). The tension time index of the diaphragm and of the respiratory muscles, phase angle (Φ), phase relation during the total breath, and labored breathing index were calculated.

RESULTS

Age at baseline study was 54-237 (median 131) days. Reliable data were obtained safely for MIP, phase angle, labored breathing index, and the invasive and non-invasive tension time indices, even in very weak infants. Data obtained corresponded to the clinical estimate of severity and predicted the need for respiratory support.

CONCLUSIONS

The testing employed was both safe and feasible. Measurements of MIP and RIP are easily performed tests that are well tolerated and provide clinically useful information for infants with SMA-I.

摘要

目的

确定对患有进行性神经肌肉疾病的虚弱婴儿进行呼吸肌功能测试的可行性和安全性。

理论依据

呼吸功能不全是Ⅰ型脊髓性肌萎缩症(SMA-Ⅰ)婴儿发病和死亡的主要原因。

假设

可以在SMA-Ⅰ型婴儿中安全地进行呼吸肌力量、耐力和呼吸模式测试。可以收集到与SMA-Ⅰ型肺功能临床病程相似的有用数据。

研究设计和受试者选择

对在我们神经肌肉诊所就诊的7名SMA-Ⅰ型婴儿的呼吸肌功能测试和呼吸模式进行探索性研究。在初次研究就诊时进行测量,并尽可能随时间纵向测量。

方法

我们使用呼吸感应体积描记法(RIP)测量最大吸气压力(MIP)和跨膈压、平均跨膈压、吸气100毫秒时的气道阻塞压、吸气和总呼吸周期时间以及相对胸腹运动的各个方面。计算膈肌和呼吸肌的张力时间指数、相角(Φ)、整个呼吸过程中的相位关系以及呼吸费力指数。

结果

基线研究时的年龄为54-237(中位数131)天。即使在非常虚弱的婴儿中,也能安全地获得关于MIP、相角、呼吸费力指数以及有创和无创张力时间指数的可靠数据。获得的数据与严重程度的临床评估相符,并预测了呼吸支持的需求。

结论

所采用的测试既安全又可行。MIP和RIP测量是易于进行的测试,耐受性良好,并为SMA-Ⅰ型婴儿提供临床有用信息。

相似文献

1
Respiratory muscle function in infants with spinal muscular atrophy type I.I型脊髓性肌萎缩症婴儿的呼吸肌功能
Pediatr Pulmonol. 2014 Dec;49(12):1234-42. doi: 10.1002/ppul.22997. Epub 2014 Apr 29.
2
Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3.脊髓性肌萎缩症 2 型和 3 型患者肺功能和呼吸肌力量的纵向病程。
Eur J Paediatr Neurol. 2013 Nov;17(6):552-60. doi: 10.1016/j.ejpn.2013.04.004. Epub 2013 May 11.
3
Alterations of thoraco-abdominal volumes and asynchronies in patients with spinal muscle atrophy type III.III型脊髓性肌萎缩症患者胸腹部容积的改变及不同步情况。
Respir Physiol Neurobiol. 2014 Jun 15;197:1-8. doi: 10.1016/j.resp.2014.03.001. Epub 2014 Mar 12.
4
Respiratory management of children with spinal muscular atrophy (SMA).脊髓性肌萎缩症(SMA)患儿的呼吸管理。
Arch Pediatr. 2020 Dec;27(7S):7S29-7S34. doi: 10.1016/S0929-693X(20)30274-8.
5
Polysomnography findings and respiratory muscle function in infants with early onset spinal muscular atrophy after gene replacement as monotherapy: A prospective study.基因替代单药治疗早发性脊髓性肌萎缩症婴儿的多导睡眠图结果和呼吸肌功能:一项前瞻性研究。
Sleep Med. 2024 Jul;119:335-341. doi: 10.1016/j.sleep.2024.05.014. Epub 2024 May 10.
6
Respiratory muscle testing: a valuable tool for children with neuromuscular disorders.呼吸肌测试:用于患有神经肌肉疾病儿童的一项宝贵工具。
Am J Respir Crit Care Med. 2006 Jul 1;174(1):67-74. doi: 10.1164/rccm.200512-1841OC. Epub 2006 Mar 30.
7
Respiratory muscle decline in Duchenne muscular dystrophy.杜氏肌营养不良症中的呼吸肌衰退
Pediatr Pulmonol. 2014 May;49(5):473-81. doi: 10.1002/ppul.22847. Epub 2013 Jul 8.
8
Respiratory muscle fatigability in patients with spinal muscular atrophy.脊髓性肌萎缩症患者的呼吸肌疲劳性。
Pediatr Pulmonol. 2022 Dec;57(12):3050-3059. doi: 10.1002/ppul.26133. Epub 2022 Sep 14.
9
The value of multiple tests of respiratory muscle strength.呼吸肌力量多项测试的价值
Thorax. 2007 Nov;62(11):975-80. doi: 10.1136/thx.2006.072884. Epub 2007 Jun 8.
10
Ultrasound assessment of diaphragmatic function in type 1 spinal muscular atrophy.1 型脊髓性肌萎缩症膈肌功能的超声评估。
Pediatr Pulmonol. 2020 Jul;55(7):1781-1788. doi: 10.1002/ppul.24814. Epub 2020 May 11.

引用本文的文献

1
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study.192例接受诺西那生治疗的脊髓性肌萎缩症(SMA)成年患者的呼吸功能——一项多中心观察性研究。
Orphanet J Rare Dis. 2025 Sep 8;20(1):476. doi: 10.1186/s13023-025-04009-3.
2
The long-term efficacy of nusinersen on respiratory functions in children with symptomatic spinal muscular atrophy type 1.诺西那生钠对1型有症状脊髓性肌萎缩症儿童呼吸功能的长期疗效。
Turk J Med Sci. 2025 Feb 2;55(3):702-709. doi: 10.55730/1300-0144.6018. eCollection 2025.
3
Fiberoptic endoscopic evaluation of swallowing (FEES) in children with spinal muscular atrophy type 1: feasibility, swallowing safety and efficacy, and dysphagia phenotype.
纤维内镜吞咽功能评估(FEES)在 1 型脊髓性肌萎缩症患儿中的应用:可行性、吞咽安全性和疗效,以及吞咽障碍表型。
Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6523-6532. doi: 10.1007/s00405-024-08922-4. Epub 2024 Sep 4.
4
Sleep and sleep-related breathing disorders in patients with spinal muscular atrophy: a changing perspective from novel treatments?脊髓性肌萎缩症患者的睡眠及与睡眠相关的呼吸障碍:新疗法带来的视角转变?
Front Neurol. 2024 Jun 4;15:1299205. doi: 10.3389/fneur.2024.1299205. eCollection 2024.
5
Respiratory function in adult patients with spinal muscular atrophy treated with nusinersen - a monocenter observational study.用诺西那生治疗的成年脊髓性肌萎缩症患者的呼吸功能——一项单中心观察性研究
Front Neurol. 2024 Apr 3;15:1372674. doi: 10.3389/fneur.2024.1372674. eCollection 2024.
6
Structured Light Plethysmography for Non-Invasive Assessment of Respiratory Pattern in Spinal Muscular Atrophy Type 1.用于无创评估1型脊髓性肌萎缩症呼吸模式的结构光容积描记法
J Clin Med. 2023 Dec 7;12(24):7553. doi: 10.3390/jcm12247553.
7
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.针对携带两个 SMN2 拷贝且有 1 型脊髓性肌萎缩症风险的婴儿进行的 Onasemnogene abeparvovec 治疗的 III 期 SPR1NT 试验。
Nat Med. 2022 Jul;28(7):1381-1389. doi: 10.1038/s41591-022-01866-4. Epub 2022 Jun 17.
8
Improved resolution of D-bar images of ventilation using a Schur complement property and an anatomical atlas.利用 Schur 补性质和解剖图谱提高通气 D -bar 图像的分辨率。
Med Phys. 2022 Jul;49(7):4653-4670. doi: 10.1002/mp.15669. Epub 2022 May 5.
9
Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy.脊髓性肌萎缩症的临床和经济证据的系统文献回顾。
Adv Ther. 2022 May;39(5):1915-1958. doi: 10.1007/s12325-022-02089-2. Epub 2022 Mar 20.
10
The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.《依库珠单抗治疗视神经脊髓炎谱系疾病的有效性和安全性的 Meta 分析》
Medicina (Kaunas). 2022 Feb 1;58(2):213. doi: 10.3390/medicina58020213.